President & Immunovant CEO
Mon, Apr 20, 2026
Apr 20
200,000 shares @ $3.85
Increased holdings by +12.10%
92nd largest trade (out of 285)
Cluster Buy
Trade made by an officer
Part of a cluster of 8 transactions by 6 insiders
10b5-1 scheduled trade
32% win rate · -6.0% median edge vs SPY (85 trades, 90-day)
Insider trade was 87% below market price
Price 46% above 200-day moving average